Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc + iron + folic acid is a combination micronutrient supplement evaluated for its potential to reduce mortality and hospitalizations in young children. This specific formulation, often delivered as a daily dispersible tablet, was the focus of a major randomized, double-blind clinical trial conducted by the Society for Applied Studies in collaboration with the World Health Organization (WHO) and the All India Institute of Medical Sciences (AIIMS). The supplement targets common nutritional deficiencies in developing regions, where zinc deficiency is linked to increased susceptibility to infectious diseases. By providing a recommended daily allowance (RDA) of zinc alongside iron and folic acid, the intervention aims to bolster immune response and reduce the burden of conditions like diarrhea and pneumonia in children aged 1 to 23 months.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc + iron + folic acid.